On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Genexplain GmbH's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€1.9M · 4 projects
- Horizon Europe€1.5M · 3 projects
- Horizon 2020€1.1M · 5 projects
Projects
12 EU-funded projects, newest first. Each links to the official record.
- HIT-GLIOPartner
Targeting tumour-host interactions in paediatric malignant gliomas to reinvigorate immunity and improve radio- and immunotherapy efficacy
Horizon Europe · 2023–2027 · Project on CORDIS ↗
€1.0Mtheir share - Chrom_rarePartner
Unveiling the molecular basis of chromatinopathies to delineate innovative therapeutic solutions
Horizon Europe · 2023–2027 · Project on CORDIS ↗
€261ktheir share - GLIORESOLVEPartner
Training the next-generation of European GLIOblastoma (translational) researchers, to RESOLVE precision targeting of the brain tumour microenvironment
Horizon Europe · 2022–2026 · Project on CORDIS ↗
€261ktheir share - PD-MitoQUANTPartner
PD-MitoQUANT – A quantitative approach towards the characterisation of mitochondrial dysfunction in Parkinson's disease
Horizon 2020 · 2019–2022 · Project on CORDIS ↗
€148ktheir share - COLOSSUSPartner
Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions
Horizon 2020 · 2018–2023 · Project on CORDIS ↗
€282ktheir share - GLIOTRAINPartner
Exploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omics
Horizon 2020 · 2017–2021 · Project on CORDIS ↗
€249ktheir share - OPTOGENERAPYPartner
Optogenetic Protein Therapy for Multiple Sclerosis
Horizon 2020 · 2017–2020 · Project on CORDIS ↗
€386ktheir share - miRNA-DisEASYPartner
microRNA biomarkers in an innovative biophotonic sensor kit for high-specific diagnosis
Horizon 2020 · 2015–2019 · Project on CORDIS ↗
€18ktheir share - RESOLVEPartner
A systems biology approach to RESOLVE the molecular pathology of two hallmarks of patients with metabolic syndrome and its co-morbidities; hypertriglyceridemia and low HDL-cholesterol
FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗
€585ktheir share - SYSMEDIBDPartner
Systems medicine of chronic inflammatory bowel disease
FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗
€500ktheir share - MIMOMICSPartner
Methods for Integrated analysis of Multiple Omics datasets
FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗
€348ktheir share - SYSCOLPartner
Systems Biology of Colorectal Cancer
FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗
€497ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Royal College of Surgeons In IrelandIreland · 4 shared projects
- Stichting Radboud UniversiteitNetherlands · 3 shared projects
- The University of ManchesterUnited Kingdom · 3 shared projects
- Vib vzwBelgium · 3 shared projects
- Institut du Cerveau et de la Moelle EpiniereFrance · 3 shared projects
- Mimetas BVNetherlands · 3 shared projects
- Centre National de la Recherche Scientifique CNRSFrance · 2 shared projects
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 2 shared projects
- Katholieke Universiteit LeuvenBelgium · 2 shared projects
- Institut National de la Sante et de la Recherche MedicaleFrance · 2 shared projects
- Consiglio Nazionale Delle RicercheItaly · 2 shared projects
- The University of EdinburghUnited Kingdom · 2 shared projects
- Helsingin YliopistoFinland · 2 shared projects
- Erasmus Universitair Medisch Centrum RotterdamNetherlands · 2 shared projects
- Ruprecht-Karls-Universitaet HeidelbergGermany · 2 shared projects
- Sorbonne UniversiteFrance · 2 shared projects
Fields it works in
Research fields recorded on its Horizon projects.
- DNA
- RNA
- biochemistry
- cardiovascular diseases
- cells technologies
- colorectal cancer
- computational science
- databases
- diabetes
- drug discovery
- epidemiology
- hepatology
- immunotherapy
- implants
Genexplain GmbH is listed on EUACC
See the startup profile for its product, team and what it is looking for.
Open the startup profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
